Catalyst Wire Dossier Catalyst Wire Dossier

MK-8325

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-8325, covering 2015-07-21 to 2015-07-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-8325 in Hepatitis C-Infected Males (MK-8325-002) [Phase 1]

See pricing